FDA - Pilot program for expedited entry of drug products, active pharmaceutical ingredients 

August 19: The Food and Drug Administration (FDA) today released a notice for publication in the Federal Register announcing a pilot program that will allow for expedited entry of imported drugs into the United States.

The FDA notice [PDF 230 KB] outlines the eligibility requirements and the process for applying for participation in the the Secure Supply Chain Pilot Program (SSCPP).


The FDA pilot program is a two-year, voluntary pilot program, intended to help prevent the importation of adulterated, misbranded, or unapproved drugs while simultaneously increasing expedited entry for specific finished drug products and active pharmaceutical ingredients imported into the United States that meet the criteria for selection under the pilot program.


  • The FDA plans to increase the rate at which entries of the finished drug products and active pharmaceutical ingredients selected for the pilot program are given a "may proceed" without human entry review or examination.
  • The FDA, thus, anticipates that participation in the program will increase the likelihood of expedited entry when products covered by the program are offered for importation into the United States.

The FDA will accept applications for participation in the SSCPP beginning September 16, 2013, and continuing through December 31, 2013.


The SSCPP is intended to be a two-year pilot, from February 2014 through February 2016.



For more information, contact a professional with KPMG’s Trade & Customs practice:


Douglas Zuvich

(312) 665-1022


Andrew Siciliano

(631) 425-6057


John L. McLoughlin

(267) 256-2614


Todd R. Smith

(949) 885-5617


Luis A. Abad

(212) 954-3094


Amie Ahanchian

(202) 533-3247


Or your local KPMG Trade & Customs professional.




©2013 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.


The KPMG logo and name are trademarks of KPMG International.


KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever.


The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.


Direct comments, including requests for subscriptions, to us-kpmgwnt@kpmg.com.
For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at:

+ 1 202 533 4366

1801 K Street NW
Washington, DC 20006.

Share this

Share this

TaxNewsFlash-Trade & Customs by year